- Home
- CTCX vs AYTU Comparison
CTCX vs AYTU Comparison
Compare CTCX & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTCX
- AYTU
- Stock Information
- Founded
- CTCX 2007
- AYTU N/A
- Country
- CTCX United States
- AYTU United States
- Employees
- CTCX N/A
- AYTU N/A
- Industry
- CTCX Medical/Dental Instruments
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- CTCX Health Care
- AYTU Health Care
- Exchange
- CTCX Nasdaq
- AYTU Nasdaq
- Market Cap
- CTCX 9.4M
- AYTU 8.3M
- IPO Year
- CTCX N/A
- AYTU N/A
- Fundamental
- Price
- CTCX $0.24
- AYTU $1.35
- Analyst Decision
- CTCX
- AYTU
- Analyst Count
- CTCX 0
- AYTU 0
- Target Price
- CTCX N/A
- AYTU N/A
- AVG Volume (30 Days)
- CTCX 259.6K
- AYTU 30.9K
- Earning Date
- CTCX 03-31-2025
- AYTU 02-12-2025
- Dividend Yield
- CTCX N/A
- AYTU N/A
- EPS Growth
- CTCX N/A
- AYTU N/A
- EPS
- CTCX N/A
- AYTU N/A
- Revenue
- CTCX $32,839.00
- AYTU $77,232,000.00
- Revenue This Year
- CTCX N/A
- AYTU N/A
- Revenue Next Year
- CTCX N/A
- AYTU N/A
- P/E Ratio
- CTCX N/A
- AYTU N/A
- Revenue Growth
- CTCX N/A
- AYTU N/A
- 52 Week Low
- CTCX $0.20
- AYTU $1.30
- 52 Week High
- CTCX $3.35
- AYTU $3.45
- Technical
- Relative Strength Index (RSI)
- CTCX 35.64
- AYTU 32.11
- Support Level
- CTCX $0.23
- AYTU $1.35
- Resistance Level
- CTCX $0.27
- AYTU $1.44
- Average True Range (ATR)
- CTCX 0.04
- AYTU 0.10
- MACD
- CTCX -0.01
- AYTU -0.02
- Stochastic Oscillator
- CTCX 9.09
- AYTU 2.63
About CTCX Carmell Corporation
Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.